If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

The head of France’s Pasteur Institute on Trump’s attacks on health institutions — and what scientists can do to rebuild public trust ...

For kids with peanut allergies, even just a whiff of peanut butter can feel like it might trigger some kind […] ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

A study at Mount Sinai has shown that children with a high tolerance for peanuts can significantly increase their resistance ...

Donald Trump is preparing an executive order to halt funding of gain-of-function research—lab experimentation designed to ...

Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.

More than 10 million in taxpayer funds were reportedly spent on invasive transgender animal experiments involving mice, rats ...

The NIH, at a time of deep uncertainty, is losing its longtime No. 2 official, Larry Tabak, to retirement, STAT has learned.

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The NIH has announced it will cap funds for “indirect costs” to grant recipients such as universities and hospitals.

The federal order temporarily halts the Trump administration’s plans to slash $4 billion in overhead costs for research at ...